Brian Piekos Gemini Therapeutics, Inc. (GMTX) insider trading activity

GMTX Quotes by TradingView

Brian Piekos is CFO of Gemini Therapeutics, Inc. . Currently has a direct ownership of 17,615 shares of GMTX, which is worth approximately $429,277. The most recent transaction as insider was on May 31, 2022, when has been sold 9,960 shares (Common Stock) at a price of $1.09 per share, resulting in proceeds of $10,856. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.6K
0% 3M change
0% 12M change
Total Value Held $429,277

Brian Piekos Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 31 2022
BUY
Grant, award, or other acquisition
$10,856 $1.09 p/Share
9,960 Added 36.12%
17,615 Common Stock
May 14 2021
BUY
Open market or private purchase
$72,416 $9.46 p/Share
7,655 Added 50.0%
7,655 Common Stock

Also insider at

AMAG
AMAG PHARMACEUTICALS, INC.
Chief Financial Officer
ANGN
Angion Biomedica Corp. Healthcare
Chief Financial Officer
KALV
KalVista Pharmaceuticals, Inc. Healthcare
Chief Financial Officer
BP

Brian Piekos

CFO
Waltham, MA

Track Institutional and Insider Activities on GMTX

Follow Gemini Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GMTX shares.

Notify only if

Insider Trading

Get notified when an Gemini Therapeutics, Inc. insider buys or sells GMTX shares.

Notify only if

News

Receive news related to Gemini Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GMTX